Talphera (TLPH) Non Operating Income (2010 - 2026)
Talphera (TLPH) posted quarterly Non Operating Income of $1.4 million for Q1 2026, up 456.8% year-over-year from $250000.0 in Q1 2025, and up 536.36% quarter-over-quarter from -$319000.0 in Q4 2025.
Talphera (TLPH) Non Operating Income (2010 - 2026) Analysis & Trends
Talphera's Non Operating Income history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Non Operating Income rose 456.8% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $263000.0 (down 88.13% YoY), while the FY2025 annual figure was -$879000.0, down 139.1% from the prior year.
- Non Operating Income for Q1 2026 stood at $1.4 million, up from -$319000.0 in the prior quarter.
- The five-year high for Non Operating Income was $84.3 million in Q2 2022, with the low at -$1.0 million in Q3 2025.
- The 5-year median for Non Operating Income is $266500.0 (2024), against an average of $5.5 million.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income jumped 49765.68% in 2022, then tumbled 356.06% in 2025.
- Talphera's Non Operating Income stood at -$51000.0 in 2022, then tumbled by 345.1% to -$227000.0 in 2023, then jumped by 596.04% to $1.1 million in 2024, then tumbled by 128.33% to -$319000.0 in 2025, then soared by 536.36% to $1.4 million in 2026.
- Business Quant data shows TLPH's Non Operating Income at $1.4 million in Q1 2026, -$319000.0 in Q4 2025, and -$1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - | -388,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -388,000.00 |
| Mar 31, 2026 | 1.39 Mn |
| Dec 31, 2025 | -319,000.00 |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | 204,000.00 |
| Mar 31, 2025 | 250,000.00 |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 396,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Mar 31, 2024 | 283,000.00 |
| Dec 31, 2023 | -227,000.00 |
| Sep 30, 2023 | 1.89 Mn |
| Jun 30, 2023 | -456,000.00 |
| Dec 31, 2022 | -51,000.00 |
| Sep 30, 2022 | -105,000.00 |
| Jun 30, 2022 | 84.27 Mn |
| Mar 31, 2022 | 321,000.00 |
| Dec 31, 2021 | 258,000.00 |
| Sep 30, 2021 | 258,000.00 |
| Jun 30, 2021 | 169,000.00 |